Literature DB >> 36008478

ctDNA guides anti-EGFR rechallenge.

Peter Sidaway1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 36008478     DOI： 10.1038/s41571-022-00681-7

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   65.011


× No keyword cloud information.
  1 in total

1.  Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial.

Authors:  Silvia Marsoni; Salvatore Siena; Alberto Bardelli; Andrea Sartore-Bianchi; Filippo Pietrantonio; Sara Lonardi; Benedetta Mussolin; Francesco Rua; Giovanni Crisafulli; Alice Bartolini; Elisabetta Fenocchio; Alessio Amatu; Paolo Manca; Francesca Bergamo; Federica Tosi; Gianluca Mauri; Margherita Ambrosini; Francesca Daniel; Valter Torri; Angelo Vanzulli; Daniele Regge; Giovanni Cappello; Caterina Marchiò; Enrico Berrino; Anna Sapino
Journal:  Nat Med       Date:  2022-08-01       Impact factor: 87.241
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.